FTSE 100 stalls as Rio Tinto, healthcare stocks weigh

The FTSE 100 dropped 0.1%, with Rio Tinto falling 3.8% as the miner traded without entitlement to the latest dividend payout. Drugmaker GSK slid 2.8% after heavy selling in the previous session amid chatter over potential negative implication from U.S. lawsuits over Zantac, a drug that was withdrawn in 2019.


Reuters | Updated: 11-08-2022 15:00 IST | Created: 11-08-2022 14:31 IST
FTSE 100 stalls as Rio Tinto, healthcare stocks weigh
Representative Image Image Credit: Flickr

Britain's top share index dipped on Thursday, weighed down by Rio Tinto and healthcare stocks, while the midcap index struggled after hitting a two-month peak earlier as the prospect of higher U.S. interest rates kept investors wary. The FTSE 100 dropped 0.1%, with Rio Tinto falling 3.8% as the miner traded without entitlement to the latest dividend payout.

Drugmaker GSK slid 2.8% after heavy selling in the previous session amid chatter over potential negative implications from U.S. lawsuits over Zantac, a drug that was withdrawn in 2019. Haleon, a consumer health company that recently spun off from GSK, dropped 7.9%. The domestically focussed FTSE 250 index also gave up earlier gains to slip 0.1%.

Global equities climbed on Wednesday after softer-than-expected U.S. inflation data reduced bets of a supersized rate hike by the Federal Reserve next month. However, policymakers were quick to say that they will continue to tighten monetary policy until price pressures are fully broken. "Market pricing suggests that investors are more dovish than what we would expect the Fed to deliver," said Karim Chedid, BlackRock's head of investment strategy for its iShares unit in the EMEA region. "You could see more volatility in rate and equity markets."

A stock market rally since June lows has helped drive the FTSE 100 and the midcap FTSE 250 near two-month highs, but many strategists doubt if the gains can sustain amid growing concerns of a recession. The focus will now be on the preliminary reading of Britain's GDP on Friday, expected to show a contraction during the second quarter.

Britain will only feel the full impact of higher interest rates in late 2023 and there is unlikely to be any return of quantitative easing for at least a few years, Bank of England chief economist Huw Pill said. London-listed shares of Antofagasta slipped 1.6% after the Chilean miner reported a fall in half-year profit.

UK-listed shares of Dubai-based payments processor Network International jumped 11.5% as it announced a stock buyback program and reported strong half-year results.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback